Burgeoning Prevalence of Cardiovascular Diseases Expected to Lead to the Growth of the Global Paediatric Genetic Testing market

Burgeoning awareness among people pertaining to newborn genetic testing, booming population, and increasing degree of advancements in molecular diagnostics for clinical diagnostics are some of the factors driving the growth of Global Paediatric Genetic Testing in 2019. Moreover, increasing investment in the R&D for innovation, burgeoning prevalence of cardiovascular diseases, coupled with escalating adoption of genetic testing services, and decreasing cost of genetic testing are strongly contributing toward the growth of the market in forthcoming timeline.

According to MarkNtel Advisors’ research report “Global Paediatric Genetic Testing Market Analysis, 2020”, the Global Paediatric Genetic Testing market is anticipated to grow at a CAGR of around 14% during 2021-26F. Based on Disorder, Neurological disorder acquired the considerable market share in 2019. This is due to rising number of neurological disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) among people, growing geriatric population, and rising government initiatives to raise awareness about neurological disorders.

View Report: https://www.marknteladvisors.com/research-library/global-paediatric-genetic-testing-market.html?utm_source=OpenPr&utm_medium=pr

“Global Paediatric Genetic Testing Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Paediatric Genetic Testing providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.

North America Accounted for Largest Market Share
North America accounted for largest market share in the Global Paediatric Genetic Testing market in 2019. US dominated the North America segment owing to the factors such as surging incidences of genetic disorders, growing awareness regarding personalized medicines, and rising investment toward advancements in genetic testing techniques. Moreover, increasing government spending in research & development, extensive awareness for newborn genetic testing, and growth in awareness regarding early screening of genetic disorders are expected to boost the growth of the Paediatric Genetic Testing Market in the forthcoming period as stated in MarkNtel Advisors’ research report “Global Paediatric Genetic Testing Market Analysis, 2020”.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @ https://www.marknteladvisors.com/query/request-sample/africa-medical-plastic-converters-market.html?utm_source=Openpr&utm_medium=pr

According to MarkNtel Advisors, the key players with a considerable market share in the Global Paediatric Genetic Testing market are Abbott Laboratories, BGI Genomics, Invitae Corporation, Trivitron Healthcare, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Quest Diagnostics, Unilabs Group Services, Agilent Technologies, Inc., Genomic Diagnostics, PerkinElmer, Inc., CENTOGENE N.V, OPKO Health, Inc., Baebies, Inc., Eurofins Scientific etc.

Market Segmentation:
1. By Product Type (Kits, Reagents, Laboratory Developed Tests (LDT))
2. By Sample Type (Saliva, Blood, Tissue, Bone Marrow)
3. By Technology (Next Generation Sequencing, Fluorescent In Situ Hybridization (FISH), Polymerase Chain Reaction, Microarray Techniques, Others)
4. By Disorder (Developmental Disorders, Cardiovascular Disorders, Neurological Disorders, Others)
5. By Application (Clinical Diagnostics, Drug Discovery, Monitoring and Screening, Academic and Research)
6. By Origin (Inherited Disorders, Somatic Disorders)
7. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
8. By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Italy, Spain, China, Japan, South Korea, India, Australia, UAE, Saudi Arabia, South Africa),
9. By Company (Abbott Laboratories, BGI Genomics, Invitae Corporation, Trivitron Healthcare, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Quest Diagnostics, Unilabs Group Services, Agilent Technologies, Inc., Genomic Diagnostics, PerkinElmer, Inc., CENTOGENE N.V, OPKO Health, Inc., Baebies, Inc., Eurofins Scientific etc.)

Key questions answered in the study:
1. What are the current and future trends of the Paediatric Genetic Testing industry?
2. How the industry has been evolving in terms of end-user demand and application areas?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Paediatric Genetic Testing industry?
5. What is the customer orientation, purchase behavior, and expectations from the Paediatric Genetic Testing firms across various regions?

MarkNtel Advisors
1147 88AVE, Delta, British Columbia, BC,V4C,3B8, CANADA
Email: updates@markntelgroup.com
Tel: +1613-707-5086
Website: https://www.marknteladvisors.com/?utm_source=Openpr&utm_medium=pr

MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.

We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.

This release was published on openPR.